title: Severe exacerbation of psoriasis after intravenous immunoglobulin in patient with multiple sclerosis that started during biologic therapy.
authors.affiliation: Department of Dermatovenereology, Third Faculty of Medicine, Charles University in Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic.
authors.forename: J
authors.initials: J
authors.lastname: Ettler
authors.affiliation: Department of Dermatovenereology, Third Faculty of Medicine, Charles University in Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic.
authors.forename: P
authors.initials: P
authors.lastname: Arenberger
authors.affiliation: Department of Dermatovenereology, Third Faculty of Medicine, Charles University in Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic.
authors.forename: M
authors.initials: M
authors.lastname: Arenbergerova
authors.affiliation: Department of Dermatovenereology, Third Faculty of Medicine, Charles University in Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic.
authors.forename: S
authors.initials: S
authors.lastname: Gkalpakiotis
mesh_terms: D000328:Adult; D001691:Biological Therapy / Q000009:adverse effects*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000009:adverse effects*; D007155:Immunologic Factors / Q000008:administration & dosage / Q000009:adverse effects; D008297:Male; D009103:Multiple Sclerosis / Q000150:complications / Q000188:drug therapy*; D011565:Psoriasis / Q000150:complications* / Q000473:pathology; D012008:Recurrence; D012720:Severity of Illness Index; D012867:Skin / Q000473:pathology*
chemical_list: D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors